FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Administration of oxandrolone, a non-aromatizable testosterone analog, to children for 12 months following severe burn injury has been shown to improve height, increase bone mineral content (BMC), reduce cardiac work, and augment muscle strength. Surprisingly, the increase in BMC persists well beyon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Shock
Autors principals: Reeves, Patrick T, Herndon, David N, Tanksley, Jessica D, Jennings, Kristofer, Klein, Gordon L, Mlcak, Ronald P, Clayton, Robert P, Crites, Nancy N, Hays, Joshua P, Andersen, Clark, Lee, Jong O, Meyer, Walter, Suman, Oscar E, Finnerty, Celeste C
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792676/
https://ncbi.nlm.nih.gov/pubmed/26506070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SHK.0000000000000517
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars